Critical evaluation of muscle mass loss as a prognostic marker of morbidity in critically ill patients and methods for its determination

Journal of Rehabilitation Medicine

Volumn 50, Issue 8, 2018, Pages 696-704

  Joskova, Vera ^a,b   Patkova, Anna ^a,b   Havel, Eduard ^b   Najpaverova, Simona ^a   Uramova, Daniela ^a   Kovarik, Miroslav ^a,b   Zadak, Zdenek ^b   Hronek, Miloslav ^a,b  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Body composition; Muscle atrophy; Myolysis; Protein catabolism; Stress metabolism

Indexed keywords

BODY MASS; CRITICAL ILLNESS; HUMAN; MORBIDITY; MORTALITY; PROGNOSIS; SURVIVAL RATE;

BODY MASS INDEX; CRITICAL ILLNESS; HUMANS; MORBIDITY; PROGNOSIS; SURVIVAL RATE;

EID: 85051853957     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-2368     Document Type: Review

References (71)

1. Robertson CL, Al-Haddad M. Recognizing the critically ill patient. Anaes Intens Care Med 2013; 14: 11–14.
2. Simsek T, Simsek HU, Canturk NZ. Response to trauma and metabolic changes: posttraumatic metabolism. Ulus Cerrahi Derg 2014; 30: 153–159.
3. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995; 98: 75–84.
4. Ilias I, Vassiliadi DA, Theodorakopoulou M, Boutati E, Maratou E, Mitrou P, et al. Adipose tissue lipolysis and circulating lipids in acute and subacute critical illness: effects of shock and treatment. J Crit Care 2014; 29: 1130 e1135–e1139.
5. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001; 15: 533–551.
6. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, et al. ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr 2009; 28: 387–400.
7. Duska F, Andel M. Intensive blood glucose control in acute and prolonged critical illness: endogenous secretion contributes more to plasma insulin than exogenous insulin infusion. Metabolism 2008; 57: 669–671.
8. Essen P, McNurlan MA, Gamrin L, Hunter K, Calder G, Garlick PJ, et al. Tissue protein synthesis rates in critically ill patients. Crit Care Med 1998; 26: 92–100.
9. Weijs PJ, Cynober L, DeLegge M, Kreymann G, Wernerman J, Wolfe RR. Proteins and amino acids are fundamental to optimal nutrition support in critically ill patients. Crit Care 2014; 18: 591.
10. Bartolo M, Bargellesi S, Castioni CA, Intiso D, Fontana A, Copetti M, et al. Mobilization in early rehabilitation in intensive care unit patients with severe acquired brain injury: an observational study. J Rehabil Med 2017; 49: 715–722.
11. Puthucheary Z, Harridge S, Hart N. Skeletal muscle dysfunction in critical care: wasting, weakness, and rehabilitation strategies. Critical Care Med 2010; 38: S676–S682.
12. Niskanen M, Kari A, Halonen P. Five-year survival after intensive care – comparison of 12,180 patients with the general population. Finnish ICU Study Group. Critical Care Med 1996; 24: 1962–1967.
13. Weijs PJ, Looijaard WG, Dekker IM, Stapel SN, Girbes AR, Oudemans-van Straaten HM, et al. Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients. Critical Care 2014; 18: R12.
14. Moisey LL, Mourtzakis M, Cotton BA, Premji T, Heyland DK, Wade CE, et al. Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Crit Care 2013; 17: R206.
15. Pichard C, Kyle UG, Morabia A, Perrier A, Vermeulen B, Unger P. Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr 2004; 79: 613–618.
16. Gruther W, Benesch T, Zorn C, Paternostro-Sluga T, Quittan M, Fialka-Moser V, et al. Muscle wasting in intensive care patients: ultrasound observation of the M. quadriceps femoris muscle layer. J Rehabil Med 2008; 40: 185–189.
17. Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. Acute skeletal muscle wasting in critical illness. JAMA 2013; 310: 1591–1600.
18. Oliveros H, Villamor E. Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity (Silver Spring) 2008; 16: 515–521.
19. Hogue CW, Jr., Stearns JD, Colantuoni E, Robinson KA, Stierer T, Mitter N, et al. The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med 2009; 35: 1152–1170.
20. Sakr Y, Elia C, Mascia L, Barberis B, Cardellino S, Livigni S, et al. Being overweight or obese is associated with decreased mortality in critically ill patients: a retrospective analysis of a large regional Italian multicenter cohort. J Critical Care 2012; 27: 714–721.
21. Habbu A, Lakkis NM, Dokainish H. The obesity paradox: fact or fiction? Am J Cardiol 2006; 98: 944–948.
22. Pickkers P, de Keizer N, Dusseljee J, Weerheijm D, van der Hoeven JG, Peek N. Body mass index is associated with hospital mortality in critically ill patients: an observational cohort study. Critical Care Med 2013; 41: 1878–1883.
23. Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipopro-tein hypothesis. Lancet 2000; 356: 930–933.
24. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011; 10: 931–941.
25. Puthucheary Z, Montgomery H, Moxham J, Harridge S, Hart N. Structure to function: muscle failure in critically ill patients. J Physiol 2010; 588: 4641–4648.
26. de Jonghe B, Lacherade JC, Sharshar T, Outin H. Intensive care unit-acquired weakness: risk factors and prevention. Critical Care Med 2009; 37: S309–S315.
27. Naber TH. Lean body mass depletion is associated with an increased length of hospital stay. Am J Clin Nutr 2004; 79: 527–528.
28. Savalle M, Gillaizeau F, Maruani G, Puymirat E, Bellenfant F, Houillier P, et al. Assessment of body cell mass at bedside in critically ill patients. Am J Physiol Endocrinol Metab 2012; 303: E389–E396.
29. Maffiuletti NA, Roig M, Karatzanos E, Nanas S. Neuromus-cular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: a systematic review. BMC Med 2013; 11: 137.
30. Shepherd S, Batra A, Lerner DP. Review of critical illness myopathy and neuropathy. Neurohospitalist 2017; 7: 41–48.
31. Bunnell A, Ney J, Gellhorn A, Hough CL. Quantitative neuromuscular ultrasound in intensive care unit-acquired weakness: a systematic review. Muscle Nerve 2015; 52: 701–708.
32. Grimm A, Teschner U, Porzelius C, Ludewig K, Zielske J, Witte OW, et al. Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Critical Care 2013; 17: R227.
33. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Critical Care Med 2003; 31: 359–366.
34. Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007; 175: 480–489.
35. De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Bro-chard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 2004; 30: 1117–1121.
36. Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006; 67: 1421–1425.
37. Ali NA, O’Brien JM, Jr., Hoffmann SP, Phillips G, Garland A, Finley JC, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008; 178: 261–268.
38. Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364: 1293–1304.
39. Thomas S, Burridge JH, Pohl M, Oehmichen F, Mehrholz J. Recovery of sit-to-stand function in patients with intensive-care-unit-acquired muscle weakness: results from the General Weakness Syndrome Therapy cohort study. J Rehabil Med 2016; 48: 793–798.
40. Casaer MP, Langouche L, Coudyzer W, Vanbeckevoort D, De Dobbelaer B, Guiza FG, et al. Impact of early parenteral nutrition on muscle and adipose tissue compartments during critical illness. Crit Care Med 2013; 41: 2298–2309.
41. Reid CL, Campbell IT, Little RA. Muscle wasting and energy balance in critical illness. Clin Nutr 2004; 23: 273–280.
42. Campbell IT, Watt T, Withers D, England R, Sukumar S, Keegan MA, et al. Muscle thickness, measured with ultrasound, may be an indicator of lean tissue wasting in multiple organ failure in the presence of edema. Am J Clin Nutr 1995; 62: 533–539.
43. Monk DN, Plank LD, Franch-Arcas G, Finn PJ, Streat SJ, Hill GL. Sequential changes in the metabolic response in critically injured patients during the first 25 days after blunt trauma. Ann Surg 1996; 223: 395–405.
44. Streat SJ, Beddoe AH, Hill GL. Measurement of total body water in intensive care patients with fluid overload. Metabolism 1985; 34: 688–694.
45. Finn PJ, Plank LD, Clark MA, Connolly AB, Hill GL. Progressive cellular dehydration and proteolysis in critically ill patients. Lancet 1996; 347: 654–656.
46. Plank LD, Connolly AB, Hill GL. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg 1998; 228: 146–158.
47. Rubbieri G, Mossello E, Di Bari M. Techniques for the diagnosis of sarcopenia. Clin Cases Miner Bone Metab 2014; 11: 181–184.
48. Ellis KJ, Eastman JD. Human body composition: in vivo methods, models, and assessment. New York: Plenum Press; 1993.
49. Svendsen OL, Haarbo J, Hassager C, Christiansen C. Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo. Am J Clin Nutr 1993; 57: 605–608.
50. Roubenoff R, Kehayias JJ, Dawson-Hughes B, Heymsfield SB. Use of dual-energy x-ray absorptiometry in body-composition studies: not yet a “gold standard”. Am J Clin Nutr 1993; 58: 589–591.
51. Ellis KJ. Human body composition: in vivo methods. Physiol Rev 2000; 80: 649–680.
52. Pietrobelli A, Wang Z, Formica C, Heymsfield SB. Dual-energy X-ray absorptiometry: fat estimation errors due to variation in soft tissue hydration. Am J Physiol 1998; 274: E808–E816.
53. Duren DL, Sherwood RJ, Czerwinski SA, Lee M, Choh AC, Siervogel RM, et al. Body composition methods: comparisons and interpretation. J Diabetes Sci Technol 2008; 2: 1139–1146.
54. Martin AD, Spenst LF, Drinkwater DT, Clarys JP. Anthropometric estimation of muscle mass in men. Med Sci Sports Exerc 1990; 22: 729–733.
55. Connolly B, MacBean V, Crowley C, Lunt A, Moxham J, Raf-ferty GF, et al. Ultrasound for the assessment of peripheral skeletal muscle architecture in critical illness: a systematic review. Critical Care Med 2015; 43: 897–905.
56. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr 1983; 37: 478–494.
57. Lukaski HC, Mendez J, Buskirk ER, Cohn SH. Relationship between endogenous 3-methylhistidine excretion and body composition. Am J Physiol 1981; 240: E302–E307.
58. Stimpson SA, Turner SM, Clifton LG, Poole JC, Mohammed HA, Shearer TW, et al. Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in rats. J Appl Physiol (1985) 2012; 112: 1940–1948.
59. Frankenfield DC, Cooney RN, Smith JS, Rowe WA. Bioelectrical impedance plethysmographic analysis of body composition in critically injured and healthy subjects. Am J Clin Nutr 1999; 69: 426–431.
60. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) 2000; 89: 465–471.
61. Heitmann BL. Impedance: a valid method in assessment of body composition? Eur J Clin Nutr 1994; 48: 228–240.
62. Gudivaka R, Schoeller DA, Kushner RF, Bolt MJ. Single- and multifrequency models for bioelectrical impedance analysis of body water compartments. J Appl Physiol (1985) 1999; 87: 1087–1096.
63. Kyle UG, Genton L, Mentha G, Nicod L, Slosman DO, Pichard C. Reliable bioelectrical impedance analysis estimate of fat-free mass in liver, lung, and heart transplant patients. JPEN J Parenter Enteral Nutr 2001; 25: 45–51.
64. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat–free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810–817.
65. Brodie D, Moscrip V, Hutcheon R. Body composition measurement: a review of hydrodensitometry, anthropometry, and impedance methods. Nutrition 1998; 14: 296–310.
66. Cartwright MS, Kwayisi G, Griffin LP, Sarwal A, Walker FO, Harris JM, et al. Quantitative neuromuscular ultrasound in the intensive care unit. Muscle Nerve 2013; 47: 255–259.
67. Watanabe Y, Yamada Y, Fukumoto Y, Ishihara T, Yokoyama K, Yoshida T, et al. Echo intensity obtained from ultrasono-graphy images reflecting muscle strength in elderly men. Clin Interv Aging 2013; 8: 993–998.
68. Gruther W, Kainberger F, Fialka-Moser V, Paternostro-Sluga T, Quittan M, Spiss C, et al. Effects of neuromuscular electrical stimulation on muscle layer thickness of knee extensor muscles in intensive care unit patients: a pilot study. J Rehabil Med 2010; 42: 593–597.
69. Reeves ND, Maganaris CN, Narici MV. Ultrasonographic assessment of human skeletal muscle size. Eur J Appl Physiol 2004; 91: 116–118.
70. Seymour JM, Ward K, Sidhu PS, Puthucheary Z, Steier J, Jolley CJ, et al. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax 2009; 64: 418–423.
71. Bird SJ. Diagnosis and management of critical illness polyneuropathy and critical illness myopathy. Curr Treat Options Neurol 2007; 9: 85–92.